Full Event Guide

 

What will you learn in 3 days?

  • Leverage DDR inhibitor, radiation and chemotherapy combinations and optimize therapeutic efficacy
  • Delve into DDR biology, genotypes & biomarker strategy with models to inform patient selection expand indications
  • Gain a birds-eye-view of the DDR landscape and future outlooks with industry leaders such as AstraZeneca, Bayer, Merck & Tesaro: a GSK Company
PARP DDR Brochure Logo